高龄患者主动脉根部置换策略:保留瓣膜的根部置换与生物Bentall比较
本研究评估≥65岁患者接受保留瓣膜的根部置换(VSRR)或生物Bentall的临床结局,两中心330例择期手术患者中VSRR占28%。
要点
- ≥65岁择期根部置换,VSRR与生物Bentall住院死亡率相似(2.1% vs 3.0%)。
- 合并症少且无显著瓣膜结构退变的高龄患者可考虑VSRR。
核心结论
- ≥65岁患者择期行VSRR或生物Bentall均可获得良好的短期和长期结局。
- 在无显著瓣膜结构退变且合并症少的老年患者中,VSRR是合适策略。
研究设计与样本
- 2004至2021年两所学术医疗中心801例≥65岁根部置换患者,排除非择期、中度及以上主动脉瓣狭窄、既往主动脉瓣置换和机械Bentall者。
- 最终330例接受VSRR(n=94,28%)或生物Bentall(n=236,72%),中位年龄71(67,75)岁。
临床怎么用
- 对≥65岁、合并症少且无显著瓣膜结构退变的择期根部置换患者,可优先考虑VSRR。
- 生物Bentall仍是高龄根部置换的可行选择,短期与长期结局良好。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Valve-sparing root replacement (VSRR) is being performed into the eighth decade of life. This study evaluated clinical outcomes in patients aged ≥65 years undergoing VSRR or Bio-Bentall. METHODS: From 2004 to 2021, 801 patients ≥65 years of age underwent root replacement at 2 academic medical centers. Nonelective cases, patients with moderate or greater aortic stenosis, previous aortic valve replacement, and mechanical Bentall procedures were excluded. In total, 330 patients underwent either VSRR (n = 94, 28%) or Bio-Bentall (n = 236, 72%). RESULTS: The median age of the cohort was 71 (67, 75) years. The VSRR group had less incidence of cerebrovascular disease (3.2% vs 11%, P = .02), bicuspid aortic valves (5.3% vs 16%, P = .01), moderate-to-severe aortic insufficiency (60% vs 76%, P = .002) and previous cardiac surgery (2.1% vs 8.9%, P = .03). Patients who underwent VSRR underwent more partial/total arch replacement (17% vs 5.5%, P = .0009) but had similar cardiopulmonary bypass and crossclamp times. Patients who underwent VSRR had less prolonged ventilation (7.5% vs 18%, P = .01) and shorter lengths of stay (7 vs 9 days, P = .001). Overall, in-hospital mortality was 3% and was similar between VSRR (2.1%) and Bio-Bentall (3.0%) groups (P = .73). Eight patients (2.4%) required reoperation on the aortic valve or proximal aorta during follow-up and was similar between groups. Patients who underwent VSRR had better long-term survival than patients who underwent Bio-Bentall (12-year: 70% vs 59%, P = .03). CONCLUSIONS: In patients ≥65 years of age, elective root replacement with either a VSRR or a Bio-Bentall can be performed with excellent short- and long-term outcomes. In the absence of significant valvular structural degeneration, VSRR is an appropriate strategy for this age group in patients with few comorbidities.
引用
- Norton EL, Patel PM, Levine D, et al. Optimal strategy for aortic root replacement in patients of advanced age: Valve-sparing root replacement or Bio-Bentall? J Thorac Cardiovasc Surg. 2026. PMID: 41796954. doi:10.1016/j.jtcvs.2026.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。